Article Type
Video
Changed
Display Headline
Zoledronic Acid Fizzles for Breast Cancer

Zoledronic acid failed to improve disease-free survival when added to adjuvant chemotherapy for women with stage II/III breast cancer, in the highly anticipated AZURE phase III trial.

Author and Disclosure Information

Publications
Oncology Practice
MDedge Hematology and Oncology
Breast Cancer ICYMI
Topics
Breast Cancer
Author and Disclosure Information

Author and Disclosure Information

Zoledronic acid failed to improve disease-free survival when added to adjuvant chemotherapy for women with stage II/III breast cancer, in the highly anticipated AZURE phase III trial.

Zoledronic acid failed to improve disease-free survival when added to adjuvant chemotherapy for women with stage II/III breast cancer, in the highly anticipated AZURE phase III trial.

Publications
Oncology Practice
MDedge Hematology and Oncology
Breast Cancer ICYMI
Publications
Oncology Practice
MDedge Hematology and Oncology
Breast Cancer ICYMI
Topics
Breast Cancer
Article Type
Video
Display Headline
Zoledronic Acid Fizzles for Breast Cancer
Display Headline
Zoledronic Acid Fizzles for Breast Cancer
Article Source

PURLs Copyright

Inside the Article